Ro
Established multi-vertical telehealth with insurance concierge for branded GLP-1
Reviewed by Designing Longevity Editorial · last fact-checked May 1, 2026
3.6
out of 5
No financial relationship with Ro. Editorial inclusion only.
Verdict in one glance
Best for
Users with commercial insurance covering branded GLP-1
Insurance concierge + manufacturer savings cards can drive Wegovy or Zepbound to $0–$25/month effective cost. No cash-pay competitor matches this math.
Patients who want one platform for multiple verticals
Ro covers weight loss, men's health, hair loss, fertility, and skincare. If you'd rather use one provider for several needs, Ro is the most credible multi-vertical option.
Users who value mature support infrastructure
Largest user base in the cohort and longest BBB tenure means the operation is well-rehearsed.
Look elsewhere if
Cash-pay users on compounded GLP-1 only
Membership stack + medication adds up. TrimRx and Eden offer all-inclusive pricing that beats Ro for users without insurance.
Users sensitive to subscription billing friction
BBB complaint pattern is consistent enough that this is a known risk: membership confusion, cancellation difficulty, refund delays.
Privacy-conscious users worried about compounder vendor management
The April 2025 FDA finasteride alert applies to Ro's compounded product mix even if not the GLP-1 line specifically.
Our take
The strongest pick in our cohort for users with commercial insurance, hands down. The insurance concierge is a genuine differentiator: on Wegovy or Zepbound with eligible coverage and a manufacturer savings card, your monthly cost drops to $0-$25, which no all-inclusive cash-pay specialist can match. The catch is the multi-product compounder relationship: the April 2025 FDA finasteride alert reflects on Ro's vendor management broadly, and BBB complaints about membership-vs-medication billing transparency are recurring. Pure cash-pay users on compounded GLP-1 will find better value at TrimRx or Eden.
Pros
- Both brand-name (Wegovy, Ozempic, Zepbound) and compounded options
- Insurance concierge handles prior authorization on branded GLP-1
- Established platform with mature support and largest user base in cohort
- BBB Accredited since 2018 (B rating)
- ConsumerAffairs review volume (21,800+) is the largest signal in our cohort and skews positive (4.4/5)
Cons
- Membership fee ($145/mo, $74/mo annual prepay) is on top of medication cost
- BBB complaints recurrently flag misleading "as low as $149/month" headline rate
- April 2025 FDA finasteride alert reflects on Ro's compounder-vendor track record
- Cancellation and refund friction is a recurring BBB complaint theme
- Compounded sourcing less transparent than vertically-integrated competitors
Pricing
$45 first month, $145/mo + medication
Turnaround
Same-day Rx after async intake
States served
All 50
Last verified
May 1, 2026
What Ro says, and what we found
The provider's own marketing claims, paired with our verdict. Color-coded so you can scan: green for verified, amber for stated-but-unconfirmed, violet for context.
Confirmed against the published Ro Body program page. Branded options include Wegovy, Ozempic, and Zepbound; compounded options vary by state availability.
Ro Body offers both branded GLP-1 medications and compounded alternatives.
ro.co/weight-loss · captured May 1, 2026 · source
Confirmed. Worth flagging for users: the membership fee is separate from medication cost. BBB complaints repeatedly cite confusion when the medication price surfaces post-intake.
Ro Body membership starts as low as $45 for the first month and $145/month thereafter, with annual prepay at $74/month equivalent.
ro.co Ro Body pricing · captured May 1, 2026 · source
Genuine differentiator. With eligible insurance and a manufacturer savings card, Wegovy or Zepbound can drop to $0–$25/month, which no all-inclusive cash-pay specialist matches.
Insurance concierge supports prior authorization for branded GLP-1 medications with commercial coverage.
ro.co/weight-loss · captured May 1, 2026 · source
Rubric breakdown
How this is scoredLicensure
20% weightActive state license, no recent disciplinary actions, no FDA enforcement.
Active multi-state licensure across 50 states; no FDA warning letter specifically on Ro at capture date. Counterweight: April 2025 FDA safety alert on compounded topical finasteride explicitly applies to compounders and telemedicine platforms, and Ro markets compounded topical finasteride, so the alert reflects on the company even though Ro wasn't named.
What we verified (4)
Roman Health Ventures, Inc. (operating entity)
Business filingLong-established corporate parent; founded 2017 as Roman, rebranded to Ro.
Checked May 1, 2026
No FDA warning letter on Ro / Roman Health Ventures
Federal databaseVerified against the FDA warning-letter database at capture date. None on record.
Checked May 1, 2026 · source
April 2025 FDA safety alert on compounded topical finasteride (industry-wide)
Federal alertFDA alert dated April 25, 2025 cites adverse events including suicidal ideation, depression, and erectile dysfunction tied to compounded topical finasteride. Ro markets compounded topical finasteride for hair loss, so the alert reflects on the company even though Ro is not named.
Checked May 1, 2026 · source
Active multi-state licensure
State licensureRo operates across all 50 states via licensed clinicians in each jurisdiction.
Checked May 1, 2026
Accreditation
20% weightPCAB, LegitScript, NABP, USP <797> stack.
BBB Accredited since July 23, 2018 with a B rating, among the longest-tenured BBB-accredited telehealth platforms. LegitScript not independently confirmed on a public-registry URL at capture date (LegitScript doesn't publish a per-merchant directory); Ro advertises on Google and Meta, which generally requires LegitScript certification, so it's a strong inference.
What we verified (3)
BBB Accredited Business since July 23, 2018
AccreditationCurrent BBB rating: B. Long-tenured accreditation is itself a positive signal.
Checked May 1, 2026 · source
LegitScript Healthcare Merchant Certification
AccreditationInferred from Ro's active Google and Meta advertising (which requires LegitScript), but LegitScript does not publish a public per-merchant directory URL we could confirm against.
Checked May 1, 2026 · source
PCAB on partner compounding pharmacies
Partner accreditationRo uses partner compounding pharmacies for compounded GLP-1; specific partner accreditations not publicly disclosed at fill level.
Checked May 1, 2026
Transparency
20% weightCoAs, ingredient sourcing, formulation disclosure.
Pricing structure is published, but BBB complaints recurrently flag that the headline 'as low as $149/month' figure is membership-only and doesn't include medication, with users learning this only after paying consultation fees. Compounded sourcing details (which 503A or 503B partner) less granular than vertically-integrated competitors like Eden.
What we verified (4)
Pricing model published on Ro Body program page
Pricing transparencyChecked May 1, 2026 · source
Membership fee disclosed alongside medication cost
Pricing transparencyBBB complaints describe the headline rate as misleading because membership and medication are billed separately and the medication cost only surfaces post-intake.
Checked May 1, 2026 · source
Compounded source pharmacy named per fill
SourcingRo uses a network of compounding partners; specific partner per fill is not surfaced publicly.
Checked May 1, 2026
"Compounded medications are not FDA-approved" disclosure published
Compliance disclosureChecked May 1, 2026
Product quality
15% weightIndependent test results, recall history, supply-chain controls.
Brand-name medications (Wegovy, Ozempic, Zepbound) carry FDA-approved quality assurance, so Ro's role is dispensing/coordination, not compounding. Compounded options come through partner pharmacies; specific testing programs not publicly detailed. No GLP-1 recalls on Ro-distributed product. The April 2025 FDA finasteride alert reflects on Ro's compounder-vendor management broadly even though it's a different product line.
What we verified (4)
No FDA recalls on Ro-distributed GLP-1 product
Recall historyChecked May 1, 2026 · source
Branded GLP-1 supply via authorized distribution
SourcingWegovy, Ozempic, and Zepbound dispensed through standard pharmaceutical supply chain.
Checked May 1, 2026
Compounded GLP-1 third-party lot testing program
TestingSpecific testing programs at partner pharmacies not publicly detailed at the per-fill level.
Checked May 1, 2026
Compounder-vendor management (cross-product line)
Vendor oversightApril 2025 FDA finasteride alert applies to compounders and telemedicine platforms; Ro's compounded topical finasteride line is in scope. Indicates a compounder-vendor track record that warrants scrutiny across product lines.
Checked May 1, 2026 · source
Pricing
15% weightValue within the category, no surprise fees, refund policy.
Membership ($145/mo standard, $74/mo annual prepay) is on top of medication. With commercial insurance + manufacturer savings cards, Wegovy and Zepbound can drop to $0-$25/mo via Ro's insurance concierge. Cash-pay users on compounded GLP-1 will find better value at all-inclusive specialists like TrimRx or Eden.
What we verified (3)
Membership pricing transparent on Ro Body page
Pricing transparency$45 first month, $145/mo standard; $74/mo on annual prepay.
Checked May 1, 2026
Insurance concierge for branded GLP-1
CoverageReal differentiator for users with commercial insurance; concierge handles prior authorization on Wegovy and Zepbound.
Checked May 1, 2026
No undisclosed fees
Billing complaintsBBB complaints describe unexpected charges and difficulty obtaining refunds, with the membership-vs-medication billing structure being the most common point of confusion.
Checked May 1, 2026 · source
Customer service
10% weightRefund policy, support quality, complaint history.
Wide review-platform split: Trustpilot 3.7/5 across ~3,200, BBB B rating accredited since 2018, ConsumerAffairs 4.4/5 across ~21,800. The ConsumerAffairs volume is significant (far larger sample than Trustpilot) and skews more positive. BBB complaints concentrate on cancellation and refund friction, especially around the membership-vs-medication billing structure.
What we verified (4)
Trustpilot rating: 3.7/5 across 3,198 reviews
External reviewChecked May 1, 2026 · source
ConsumerAffairs rating: 4.4/5 across 21,848 reviews
External reviewLargest external review sample in our cohort; meaningfully more positive than Trustpilot.
Checked May 1, 2026 · source
BBB B rating, accredited since 2018
Complaint historyB rating is solid. Long-tenured accreditation. Complaints concentrate on billing-structure transparency and cancellation friction.
Checked May 1, 2026 · source
Adverse-event reporting path documented
SafetyChecked May 1, 2026
Public reviews
What we found across third-party review platforms. These are external sentiment signals, not our scoring inputs.
Trustpilot
3.7 stars across 3,198 reviews, "Average" per Trustpilot's banding. Strongest themes: convenience, ease of use, professional support. Negatives concentrate on cancellation friction and surprise charges.
Better Business Bureau
BBB Accredited since July 23, 2018; current rating B. Telemedicine business in New York, NY. Complaint patterns: misleading headline pricing (membership vs medication), unexpected charges, refund difficulties on cancellation.
ConsumerAffairs
Markedly more positive than Trustpilot or BBB: 4.4/5 across 21,848 reviews. Largest review sample in our cohort by an order of magnitude. The split between platforms is wide enough to weigh both: ConsumerAffairs volume is meaningful, BBB pattern is also meaningful.
Regulatory & legal history
FDA enforcement actions, manufacturer lawsuits, recalls, and other notable events on the public record.
- FDA Warning LetterApril 25, 2025
FDA safety alert on compounded topical finasteride products cites 32 reports of adverse events between 2019-2024, including suicidal ideation, anxiety, depression, erectile dysfunction, and persistent symptoms after discontinuation. The alert applies to compounders and telemedicine platforms; Ro markets compounded topical finasteride for hair loss and is in scope even though not named in the alert.
Source
What to expect
- 1
Async intake form
10-15 minOnline intake covering current weight, BMI, medical history, medications, and weight-loss goals. Insurance information optional but recommended for branded GLP-1 path.
- 2
Clinician review + insurance check
Same day or next business dayLicensed clinician reviews intake. If branded medication is sought and insurance is provided, the insurance concierge runs eligibility and prior-authorization workflows in parallel.
- 3
Pharmacy fulfillment
3-7 daysApproved Rx routes to either an in-network pharmacy (branded) or a partner compounding pharmacy (compounded). Cold-chain shipping handled by the fulfilling pharmacy.
- 4
Ongoing care + auto-renewal
OngoingRo Body membership runs as a subscription. Cancellation and refund friction is the most common BBB complaint theme; review terms before committing and cancel through the documented in-app flow rather than letting it auto-renew if you're stopping.
Accreditations
State pharmacy/clinic license
Verified · May 1, 2026
LegitScript Certified
Unverified · May 1, 2026 · source
Frequently asked
Is Ro legit?
Yes. Ro is one of the largest direct-to-consumer telehealth platforms in the US, founded in 2017 as Roman and operating under Roman Health Ventures, Inc. BBB-Accredited with a B rating since July 23, 2018 (the longest BBB tenure in our compounded-GLP-1 cohort), no FDA warning letters on the GLP-1 line, and the largest user base in our cohort by ConsumerAffairs review volume (4.4/5 across roughly 21,800 reviews). The honest counterweight is the April 2025 industry-wide FDA safety alert on compounded topical finasteride; Ro markets compounded topical finasteride for hair loss, so the alert reflects on Ro's compounder-vendor management broadly even though Ro is not specifically named. For users with insurance covering Wegovy or Zepbound, Ro is our top pick given the insurance-concierge pathway that can drop effective monthly cost to $0-$25.
Is Ro the same as Roman?
Yes. Ro was founded in 2017 as Roman, focused on men's health (ED, hair loss). The company rebranded to Ro and expanded into multiple verticals including weight loss (Ro Body), women's health, fertility, and dermatology. Operating entity is Roman Health Ventures, Inc., based in New York.
Is Ro BBB-accredited?
Yes. Ro has been BBB Accredited since July 23, 2018 with a current rating of B. The profile is at https://www.bbb.org/us/ny/new-york/profile/telemedicine/ro-0121-173581 if you want to read complaints directly. Long-tenured BBB accreditation is itself a positive signal.
How much does Ro Body cost in total?
It depends on which medication. Membership runs $45 first month, $145/month standard ($74/month equivalent on annual prepay), separate from medication. Compounded GLP-1 can be ~$200–$400/month medication cost on top of membership. With commercial insurance covering branded Wegovy or Zepbound and manufacturer savings cards, effective monthly cost can drop to $0–$25 thanks to the insurance concierge.
Why is Ro flagged for the FDA finasteride alert?
On April 25, 2025, the FDA issued a safety alert about compounded topical finasteride products, citing 32 reports of adverse events including suicidal ideation, anxiety, and persistent symptoms after discontinuation. The alert explicitly applies to compounders and telemedicine platforms. The FDA didn't name Ro specifically, but Ro markets compounded topical finasteride for hair loss, so the alert reflects on the company's compounder-vendor management even though it's a different product line from GLP-1.
Why is Ro's Trustpilot score so different from ConsumerAffairs?
Trustpilot is 3.7/5 across ~3,200 reviews; ConsumerAffairs is 4.4/5 across ~21,800. The split is real and worth knowing. ConsumerAffairs has the larger sample by an order of magnitude, which gives it more weight on law-of-large-numbers grounds. BBB complaints (lower volume but specific) cluster around membership-vs-medication billing confusion. Read all three for a full picture.
Should I use Ro for compounded GLP-1 or branded?
If you have insurance covering Wegovy or Zepbound, Ro is the strongest pick in our cohort because of the insurance concierge: you can land at $0–$25/month effective. If you're cash-pay and looking at compounded GLP-1, TrimRx and Eden offer all-inclusive pricing that's typically better value than Ro's membership-plus-medication structure.
How do I cancel Ro Body?
Cancellation friction is the most common BBB complaint theme. The cleanest path is to cancel through the documented in-app flow before your next billing cycle; don't let auto-renewal trigger if you're stopping. If you hit obstacles, BBB complaints document a pattern of needing to escalate. Document everything in writing.
Update history
Every meaningful change to this profile, with a date stamp. We don't silently re-score.
- May 1, 2026
Initial published profile. Sources HEAD-checked at publish time. Score reflects honest math after surfacing the April 2025 FDA finasteride alert (industry-wide but applies to Ro's product mix), the BBB complaint pattern around membership-vs-medication billing transparency, and the wide review-platform split (Trustpilot 3.7 vs ConsumerAffairs 4.4 vs BBB B). Insurance concierge for branded GLP-1 remains the genuine differentiator.
Compare Ro head-to-head
Stuck choosing? We pick a winner per use case in the comparisons below.
vs Mochi Health
Independent head-to-head: Mochi Health vs Ro for GLP-1. Flat-rate compounded pricing and pharmacy enforcement vs the insured incumbent.
See verdictvs Eden
Independent head-to-head: Ro vs Eden for GLP-1 weight loss. Insurance pathway and platform breadth vs in-house compounding pharmacy and lower oral pricing.
See verdictvs Henry Meds
Independent head-to-head: Ro vs Henry Meds for GLP-1. Insurance pathway and BBB tenure vs the cheapest option with an active Lilly lawsuit.
See verdictvs Hims & Hers
Independent head-to-head: Ro vs Hims for Wegovy and Ozempic. Insurance pathway, BBB rating, FDA history, and real pricing compared.
See verdictvs TrimRx
Independent head-to-head: TrimRx vs Ro for compounded GLP-1. Top-rated specialist with the strongest accreditation vs the incumbent.
See verdictReviewed by Designing Longevity Editorial. Last fact-checked May 1, 2026.
Spot something out of date or wrong? Let us know and we'll re-check.
Back to all providers